Screener / SEC EDGAR /CIK 0001159152 /Numbers from the XBRL of the 10-Ks
NYSE, OTC Materials · Concrete Products, Except Block & Brick

James Hardie Industries plc JHX

Compare with peers Embed
SEC comment letters, last 20 years

7 reviews of JHX's filings by SEC staff

UPLOAD and CORRESP
Reviews 7 latest letter Nov 21, 2019
Questions asked 49 each answered in the company's own letter
No closing letter 1 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 10 UPLOAD
  2. 2. Questions in them 49 numbered comments
  3. 3. Company replies 10 CORRESP
  4. 4. Reviews closed 6 of 7 closing letter

Half the closed reviews took 62 days or less from the first letter to the closing letter.

Form 20-F for the Year Ended March 31, 2019

2019-11-21 to 2020-01-08 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2020-01-08
Controls
SEC asked
We note that you amended your Form 20-F to include additional disclosures to indicate the scope of your assessment of the effectiveness of internal control over financial reporting for the fiscal year ended March 31, 2019 did not include the operations of Fermacell.
Rest of the question

Given the revisions to your Form 20-F, please address the following: • Please help us understand why Management's Report on Internal Control Over Financial Reporting and the Opinion on Internal Control Over Financial Reporting from your independent auditor in your Form 20-F filed on May 21, 2019 did not include this disclosure; • Please help us understand the specific facts and circumstances that occurred after your initial filing that resulted in you amending your Form 20-F on August 8, 2019, including how you identified the omission of this disclosure in your Form 20-F; • In your amended Form 20-F you conclude that your disclosure controls and procedures were effective as of March 31, 2019. Please explain to us how you considered the definition of disclosure controls and procedures provided in Rule 13a15(e), which indicates that effective controls and procedures would ensure that information required to be disclosed by the issuer is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms. Please explain to us how and why you concluded your disclosure controls and procedures are effective in light of the previously omitted disclosures; and • Please explain to us how you re-evaluated whether your internal control over financial reporting was effective as of March 31, 2019.

JHX answered
As we discussed with you on our call on Monday, November 25, 2019, the Company has received the Comment Letter and understands the Staff’s questions with respect to the filing of the Form 20-F Amendment in order to specifically address the Company’s exclusion of the operations of XI (DL) Holdings GmbH (n/k/a James Hardie Europe Holdings 2 GmbH) and its subsidiaries (including, but not limited to, Fermacell GmbH (n/k/a James Hardie Europe GmbH)) (collectively, “Fermacell”) from management’s assessment of the effectiveness of internal control over financial reporting for the fiscal year ended
Rest of the answer

March 31, 2019. We understand the Staff’s questions center around the Company’s reasoning or purpose for filing the 20-F Amendment and whether such amendment indicates the Company’s disclosure controls and procedures were effective or not.

As an initial matter, in Question and Answer Number 3 (“FAQ # 3”) of Management’s Report on Internal Control over Financial Reporting and Certification of Disclosure Controls in Exchange Act Periodic Reports - Frequently Asked Questions (revised Sept. 24, 2007), issued by the Office of the Chief Accountant and the Division of Corporation Finance, the SEC Staff indicates that it would not object to management (in its report on internal control over financial reporting included in a registrant’s Form 10-K) excluding an acquired business from management’s report on internal control over financial reporting (which guidance is presumably applicable to a registrant’s annual report filing on Form 20-F). Such an exclusion is allowed if it was not possible for management to conduct an assessment of the acquired business’ internal control over financial reporting in the period between the consummation date and the date of management’s assessment. The SEC also indicated in Section 214.01 of the Compliance and Disclosure Interpretations of

Regulation S-K updated July 8, 2011 (“CDI # 214”) that it would not object to management’s evaluation of disclosure controls and procedures excluding an assessment of those disclosure controls and procedures of the acquired entity that are subsumed by internal control over financial reporting.

As disclosed in the Form 20-F, the Company completed the acquisition of Fermacell on April 3, 2018. Management was unable to complete its assessment of the acquired business’s internal control over financial reporting by the filing of the Form 20‑F because the acquired business was a carve-out from a larger business, the nature and number of transition services agreements in connection with the acquisition, identification of full-time employees to be assessed, and the increased complexity of the acquired business’s internal controls due to its geographic footprint. Accordingly, management excluded Fermacell from its assessment of the effectiveness of the Company’s internal control over financial reporting and disclosure controls and procedures as of March 31, 2019, as permitted by FAQ # 3 and CDI # 214.

The Company disclosed the exclusion on page 178-179 of the Form 20-F under the Risk Factor caption: “Ineffective internal controls over financial reporting could impact our business and operating results” stating in relevant part:

[A]s Fermacell was acquired on 3 April 2018, our management evaluation and auditor attestation regarding the effectiveness of our internal controls over financial reporting as of 31 March 2019 excludes the operations of Fermacell.

In addition, we note the Fermacell acquisition, and its materiality to the Company, was addressed in Notes to the Consolidated Financial Statements under the captions “3. Revenue”; “18. Operating Segment Information and Concentrations of Risk;” and “20. Business Combinations.”

Subsequent to the filing of the Form 20-F, it was brought to the attention of the Company, management, and its Audit Committee that while the exclusion of Fermacell was referenced on pages 178-179 of the Form 20-F, the Company’s disclosure under “Controls and Procedures” on pages 191-192 omitted such disclosure. Such omission on pages 191-192 was due to an administrative oversight. The Company determined that it would amend the Form 20-F to reiterate the exclusion of Fermacell from management’s evaluation under the caption “Management’s Report on Internal Control over Financial Reporting” to resolve the administrative oversight and more fully comply with the terms of FAQ # 3 and CDI # 214.

The Company evaluated the disclosure omission and determined that it was not indicative of a material weakness in its disclosure controls. In evaluating whether the Company’s disclosure controls and procedures were effective, the Company concluded all the information required to be disclosed, including the exclusion of the operations of the acquired business from management’s internal control evaluation as of March 31, 2019, as well as the materiality of the acquisition, was included in the Form 20-F filed on May 21, 2019. In arriving at this conclusion, the Company considered the nature of the omitted disclosure and the disclosures the Company did make regarding Fermacell on pages 178-179 of the Form 20-F. As noted previously, the Company amended the Form 20-F to resolve the administrative oversight by clarifying and stating directly within management’s report that Fermacell was excluded from management’s evaluation of internal control over financial reporting.

The disclosure of the exclusion of Fermacell within the Opinion on Internal Control Over Financial Reporting was also an administrative oversight by the Company’s external auditor, Ernst & Young LLP.

The omitted disclosure and nature of the disclosures are outside the scope of internal controls over financial reporting, therefore the Company concluded a re-evaluation of the effectiveness of internal control over financial reporting was not required. Notwithstanding the above, the Company is not aware of anything that has transpired that would require the Company to amend Management’s Annual Report on Internal Control Over Financial Reporting. We appreciate your prompt attention to this matter. If we can be of any further assistance, or if you have any questions regarding the concerns detailed in this letter, please do not hesitate to call me at (949) 451-4343.

Read in the reply

Also in this review: closing letter, 2020-01-08

Form 20-F for the Year Ended March 31, 2018

2019-03-22 to 2019-04-17 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2019-04-17
SegmentsIncome taxesCritical estimates
Consolidated Financial Statements
SEC asked
Income Taxes, page 145 1. We note your disclosures related to the adoption of ASU 2016-16. Please more fully address the following: • Clarify the nature of the internal restructuring you undertook to align certain intangible assets; • Disclose how you determined the amount of the related tax valuation allowance you recorded; and • To the extent your realization of net deferred tax assets is subject to material
Rest of the question

assumptions and estimates, revise your critical accounting policies to disclose and discuss the assumptions and estimates, including, if applicable, the jurisdictions to which they relate. 17. Operating Segment Information and Concentration of Risk, page 153 2. Please revise your geographic disclosures to present net sales and identifiable assets related to the U.S. as required by ASC 280-10-50-41. To the extent that substantially all the amounts disclosed for North America relate to the U.S., please clarify that fact. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

JHX answered
to the Staff’s comment, the Company intends to include clarifying disclosure in the Form 20-F for the year ending March 31, 2019 indicating the amounts disclosed for North America are substantially all related to the U.S.

To the extent you have any follow-up questions or comments, please feel free to call the undersigned at (312) 705-6125. In addition, please send all written correspondence directly to the undersigned, with copies to James J. Moloney of Gibson, Dunn & Crutcher LLP, 3161 Michelson Drive, 12th Floor, Irvine, California 92612 or via e-mail at [email protected].
Read in the reply

Also in this review: closing letter, 2019-04-17

Form 20-F for the Year Ended March 31, 2012

2013-01-09 to 2013-04-15 · 13 questions · 2 letters from the SEC, 3 from the company
Review closed 2013-04-15
Non-GAAP measuresIncome taxesLiquidity and cashGoodwill and impairmentResults discussion (MD&A)DebtLegal and contingencies
General
SEC asked (1)
Where a comment below requests additional disclosures or other revisions to be made, please show us in your supplemental response what the revisions will look like. These revisions should be included in your future filings, including your interim filings, if applicable.
JHX answered
James Hardie Industries plc is a limited liability company incorporated in Ireland with its registered office at

Europa House, Harcourt Centre, Harcourt Street, Dublin 2, Ireland.

Directors: Michael Hammes (Chairman), Brian Anderson (USA), David Dilger, David Harrison (USA),

Alison Littley (United Kingdom), Donald McGauchie (Australia), James Osborne, Rudy van deer Meer (Netherlands),

Chief Executive Officer: Louis Gries

Company number: 485719

Mr. Rufus Decker

Page

We acknowledge your comment and will provide additional disclosure or other revisions supplementally as requested.
Rest of the answer

We will include the additional disclosure or other revisions as noted below in future filings, including interim financial reports that are furnished to the Staff on our Form 6-K, as applicable.

Read in the reply
Year Ended 31 March 2012 Compared to Year Ended 31 March 2011, page 89 · Income Tax Benefit (Expense), page 93
SEC asked (2)
When you present or discuss changes between periods in a non-GAAP financial measure as an amount or percentage, such as but not limited to your discussion of the effective tax rate of earnings excluding asbestos, asset impairments, and tax adjustments, please ensure that you do so in the same manner with the comparable GAAP financial measure. Refer to Item 10(e) of Regulation S-K.
JHX answered
We note the Staff’s comment regarding the use of non-GAAP financial measures, including but not limited to the effective tax rate of earnings excluding asbestos, asset impairments and tax adjustments. The Company will expand its disclosures in future filings to include a discussion of changes between periods in the comparable GAAP financial measure in the same manner that it discusses changes in the non-GAAP financial measure.
Rest of the answer

We respectfully advise the Staff that the Company has provided a reconciliation of non-GAAP financial measures, including the effective tax rate of earnings excluding asbestos, asset impairments and tax adjustments, beginning on page 100 of the Form 20-F.

The following is an example of the anticipated revision to our future disclosure based on page 93 of our Form 20-F:

The Company’s U.S. GAAP effective tax rate is not meaningful, as it was favourably impacted by RCI’s successful appeal of the ATO’s disputed 1999 amended tax assessment, resulting in an income tax benefit of US$485.2 million in fiscal year 2012, compared to an income tax expense of US$345.2 million in fiscal year 2011, as further discussed below. The Company’s effective tax rate was also impacted by asbestos adjustments and an asset impairment charge incurred in fiscal year 2012.

The Company’s effective tax rate excluding asbestos, asset impairments and tax adjustments was 22.9% in fiscal year 2012, compared to

31.1% in fiscal year 2011, due to a higher proportion of taxable jurisdictions with lower statutory income tax rates. The Company’s geographic mix of earnings and expenses is also affected by fluctuations in foreign currency exchange rates of the US dollar to relevant local jurisdiction currencies.

Read in the reply
Liquidity and Capital Resources, 103
SEC asked (3)
Since your foreign operations appear to be significant, please disclose the following:  The amount of cash and short-term investments held by foreign subsidiaries as compared to your total amount of cash and short-term investments as of year-end;  You would be required to accrue and pay taxes to repatriate these funds and you do not intend to repatriate them, if true; and  Quantify the amount of cash and
Rest of the question

short-term investments held by foreign subsidiaries where the funds are not readily convertible into other foreign currencies, including U.S. dollars. Please also explain the implications of any such restrictions upon your liquidity. Refer to Item 303(a)(1) of Regulation S-K, SEC Release 33-8350 Section IV and Financial Reporting Codification 501.06.a.

JHX answered
We note the Staff’s comment regarding cash and short term investments held by our foreign subsidiaries. We respectfully advise the

Staff that, in accordance with SEC Release 33-8350 Section IV, we have limited our discussion of liquidity and capital resources to those matters that we believe are material to critically assess our ability to generate cash and to meet existing and known or reasonably likely future cash requirements.
Rest of the answer

On that basis, we believe our current disclosures regarding liquidity and capital resources are sufficient based on the following:

We are a public limited company domiciled in, and resident for tax purposes in, Ireland. The Company has centralized its treasury and cash management function in Ireland. Accordingly, we supplementally advise the Staff that the amount of cash held by non-Irish subsidiaries at March 31, 2012 is immaterial.

The Company’s significant cash balance at March 31, 2012 arose due to a tax refund of US$396.3 million received by a non-Irish subsidiary, which was held by our centralized treasury and cash management function in Ireland at March 31, 2012. We respectfully advise the Staff that, on page 106 of our Form 20-F, the Company disclosed that it was not required to recognize deferred taxes in association with undistributed profits of this non-Irish subsidiary.

Since we do not have any material cash or short-term deposits held by non-Irish subsidiaries, we do not have funds that are not readily convertible into other foreign currencies, and therefore have no such material restrictions on our liquidity that would merit additional disclosure regarding such restrictions.

Read in the reply
Notes to the Financial Statements · Note 9. Long-Term Debt, page 129
SEC asked (4)
You disclosed that you were in compliance with all debt covenants at March 31, 2012. Please disclose the specific terms of these debt covenants with any required ratios/amounts. Please disclose the actual ratios/amounts as of each reporting date for any material debt covenants for which it is reasonably likely that you will not be able to meet.
Rest of the question

Please also consider showing the specific computations used to arrive at the actual ratios/amounts with corresponding reconciliations to US GAAP amounts. See Sections I.D and IV.C of the SEC Interpretive Release No. 33-8350 and Compliance and Disclosures Interpretation 102.09 which is available on our website at http://www.sec.gov/divisions/corpfin/guidance/nongaapinterp.htm.

JHX answered
We note the Staff’s comment seeking additional disclosure of the specific terms, ratios/amounts and specific computations related to the Company’s debt covenants. We respectfully advise the Staff that the Company held a significant cash balance at

March 31, 2012 and, as reported on page 130 of our Form 20-F, the Company had no outstanding debt and disclosed the nature of the debt covenants to which we are subject.
Rest of the answer

We believe our current disclosure regarding our debt covenants is sufficient based on the following:

We expect to remain well within our debt covenants, and we do not believe that we are reasonably likely to breach, or be at risk of breaching, any of our debt covenants in the foreseeable future.

We do not believe our debt covenants are reasonably likely to materially limit our ability to undertake future financings to meet our future capital requirements, including the payment of dividends to shareholders.

However, we will seek to enhance our disclosure in future filings, in accordance with the Staff’s comment, in the event we believe our debt covenants are reasonably likely to have a material adverse effect on our liquidity and capital resources, as noted above.

Read in the reply
Form 6-K Filed November 16, 2012 · Exhibit 99.2
SEC asked (5)
You present non-GAAP forward-looking information, including net operating profit excluding asbestos and earnings excluding asbestos, ASIC expenses, and tax adjustments. Please present the most directly comparable GAAP financial measures and provide a quantitative reconciliation of the differences between the non-GAAP and GAAP financial measures, to the extent available without unreasonable efforts.
Rest of the question

Refer to Item 100(a) of Regulation G.

JHX answered
We note the Staff’s comment regarding the use of non-GAAP forward looking information in our earnings guidance, including the Company’s fiscal year 2013 forecasted net operating profit excluding asbestos, ASIC expenses and tax adjustments.

We supplementally advise the Staff that the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP is net income (net operating profit).

The U.S. GAAP financial measure of net operating profit includes adjustments for certain asbestos-related assets and liabilities that are actuarially assessed on an annual basis.
Rest of the answer

As disclosed on page 124 of our Form 20-F, adjustments in the asbestos liability and related insurance receivable due to changes in the actuarial estimate of projected future cash flows, changes in the estimate of future operating costs of AICF and changes in the assessment of recoverability under existing insurance policies held by AICF are reflected in the consolidated statements of operations during the period in which they occur. We respectfully advise the Staff that we are unable to determine, without unreasonable effort, the impact of changes in actuarial estimates on our asbestos-related assets and liabilities, which could have a material impact on our forecasted earnings.

Because we are unable to forecast, without unreasonable effort, the impact of movements in actuarial estimates on our asbestos-related assets and liabilities in future periods, we are unable to present the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.

In future filings, the Company will modify its disclosure indicating that it is unable to provide, without unreasonable effort, a quantitative reconciliation of the differences between the non-GAAP and comparable GAAP forward-looking financial measure. The following is an example of the anticipated revision to our future disclosure based on page 5 of Exhibit 99.2 (Media

Release) of our Form 6-K:

Full Year Earnings Guidance

Management expects full year earnings excluding asbestos, ASIC expenses and tax adjustments to be between US$140 million and US$150 million assuming, among other things, housing industry conditions in the United States continue to improve, the accounting provision for New Zealand product liability expenses remains adequate and that an average exchange rate of approximately

US$1.04/A$1.00 applies for the balance of the year ending 31 March 2013. The Company is unable to forecast the comparable U.S. GAAP financial measure due to uncertainty regarding the impact of actuarial estimates on asbestos-related assets and liabilities in future periods.

Read in the reply
Exhibit 99.3
SEC asked (6)
You present operating profit before income taxes and net operating profit. You include net interest (expense) income and other income (expense) in your determination of operating profit before income taxes. Your Form 20-F for the year ended March 31, 2012 as well as the financial statements provided in Exhibit 99.5 of this Form 6-K present an operating income line item which excludes interest expense, interest
Rest of the question

income, and other income (expense). In this regard, please tell us how you determined it was appropriate to include net profit before income taxes in the financial information provided in Exhibit 99.2. Please also tell us what consideration you gave to changing the description of the line item currently described as EBIT to operating income to be consistent with the financial statements provided in your Form 20-F for the year ended March 31, 2012 as well as the financial statements provided in Exhibit 99.5 of this Form 6-K.

JHX answered
We note the Staff’s comment regarding the presentation of different financial statement measurements used in the Condensed Consolidated Financial Statements and Management’s Analysis of Results, included as exhibits 99.5 and 99.3, respectively, to our Form 6-K.

The Company respectively advises the Staff that, included in our Form 6-K on pages 8 and 14 of Exhibit 99.2 and 99.3, respectively, is a

“Definitions” section which provides an appropriate cross reference to U.S. GAAP financial measures included in the Condensed Consolidated Financial Statements.
Rest of the answer

In the “Definitions” section of the Form 6-K dated November 16,

2012, the Company noted that operating profit is equivalent to the U.S. GAAP measure of income.

In future filings, the Company will modify its “Definitions” section to clarify how operating profit before income taxes in Exhibit 99.3 cross references to the Condensed Consolidated Financial Statements included in Exhibit 99.5. The following is an example of the anticipated revision to our future disclosure based on page 14 of Exhibit 99.3 (Management’s Analysis of Results) of our Form 6-K:

Operating profit before income taxes – is equivalent to the US GAAP measure of income before income taxes.

Read in the reply
Exhibit 99.3
SEC asked (7)
You present a full non-GAAP balance sheet, statement of operations, and statement of cash flows. Please revise your presentation to provide relevant information to investors without providing full non-GAAP financial statements. For additional guidance, please refer to Compliance and Disclosures Interpretation 102.10 which is available on our website at
JHX answered
We note the Staff’s comment regarding the presentation of full non-GAAP financial statements in Exhibit 99.3 of our Form 6-K. In this regard, we note that Compliance and Disclosures Interpretation 102.10 expresses the Staff’s view, without modifying Regulation G, that it generally would be inappropriate to present a full non-GAAP income statement for purposes of reconciling non-GAAP measures to the most directly comparable U.S.
Rest of the answer

GAAP measures.

The Company acknowledges that the inclusion of full non-GAAP financial statements would generally be inappropriate and, on that basis, did not include such information in Exhibit 99.3 of our Form 6-K prior to the Company’s 2006 fiscal year, and has always excluded such information from our annual report on Form 20-F.

However, beginning with our 2006 fiscal year, and as disclosed on page 123 of our Form 20-F, we are required to consolidate Asbestos

Injuries Compensation Fund (“AICF”). Although we have no legal ownership in AICF, we consolidate AICF into our consolidated financial statements as a variable interest entity under U.S. GAAP due to our pecuniary and contractual interests in AICF as a result of the funding arrangements outlined in the Amended and Restated Final Funding Agreement (“AFFA”), which relates to a contractual settlement for personal injuries that arose from our use of asbestos in Australia.

Accordingly, we record on our consolidated balance sheets certain asbestos-related assets and liabilities of AICF under the terms of the AFFA. These asbestos-related assets and liabilities are Australian dollar-denominated and are subject to actuarial adjustments and translation into US dollars at each reporting date, which materially impact our consolidated results of operations. Accordingly, users of our financial statements, including lenders, institutional investors and analysts have expressed concern in being able to properly assess the Company’s ongoing financial position, results of operations and cash flows on a basis that de-consolidates AICF, if such information were to be excluded from our Form 6-K.

Accordingly, while the Company notes the Staff’s view in Compliance and Disclosures Interpretation 102.10 that it is generally inappropriate to include full non-GAAP financial statements, we believe the unique nature of the terms and conditions of the AFFA, to which we are subject, and the reporting needs of our stakeholders, warrant inclusion of these non-GAAP financial statements in our Form 6-K to enable users to properly assess the impact of the terms and conditions of the AFFA on our financial position, results of operations, and cash flows. Accordingly, we have included such tables on the following basis:

Unlike domestic issuers, we are not required to file quarterly reports with the Staff on a Form 10-Q, nor are we required to provide such quarterly reports to a governmental regulatory authority or self-regulatory organization outside the United States. Further, since such tables are not expressly prohibited from inclusion in our reports by our home stock exchange listing rules, these tables are included in our quarterly results materials that are furnished to the Staff on Form 6-K in accordance with the continuous disclosure requirements in Rule 13a-16 of the Securities Exchange Act of 1934, but are appropriately excluded from our annual report on Form 20-F that is filed with the Staff pursuant to the Securities Exchange Act of 1934.

These tables contain line items that are presented in a manner that is consistent with our U.S. GAAP consolidated financial statements. Additionally, the ‘As Reported’ column, which is the summation of the ‘Total Fibre Cement Operations-excluding Asbestos

Compensation’ and the ‘Asbestos Compensation’ columns, agrees to the corresponding financial statement in the aggregate and by line item, as included in the consolidated financial statements in accordance with U.S. GAAP. This layout is intended to assist the reader in understanding how these tables tie into the consolidated financial statements presented in accordance with U.S. GAAP.

The sole purpose of these tables is to separate the impact of the terms and conditions of the AFFA, but continue to reflect the impact of all adjustments which, in our opinion, are necessary to state fairly our financial position, results of operations and cash flows in accordance with U.S. GAAP.

We have explicitly cautioned the reader on page 17 of Exhibit 99.3 of our Form 6-K that these tables are not intended to be used or viewed as substitutes for the Company’s consolidated financial statements prepared in accordance with U.S. GAAP, but should be read in conjunction with the consolidated financial statements and accompanying footnotes as a supplement.

Accordingly, we respectfully advise the Staff that, in our opinion, while it is generally inappropriate to include full non-GAAP financial statements, the unique nature of the impact the AFFA has on our consolidated financial position, results of operations and cash flows, together with the needs of the users of our financial statements, warrant inclusion of these tables on our Form 6-K. Further, we believe that the manner in which these tables are presented minimize the risk of attaching undue prominence to the ‘non-GAAP’ financial information and adheres to the purpose and intent of Compliance and Disclosures Interpretation 102.10.

* * * *

You may call the undersigned with any questions or comments you may have regarding this letter at (312) 705-6192. In addition, please send all written correspondence directly to the undersigned, with copies to James J. Moloney of Gibson, Dunn & Crutcher LLP, 3161 Michelson Drive, Irvine, California 92612, facsimile (949) 475-4756.

Read in the reply
General
SEC asked (1)
Where a comment below requests additional disclosures or other revisions to be made, please show us in your supplemental response what the revisions will look like. These revisions should be included in your future filings, including your interim filings, if applicable.
JHX answered
We acknowledge your comment and hereby provide the additional disclosure or other revisions as requested. We will include the additional disclosure or other revisions as noted below in future filings, including interim financial reports that are furnished to the Staff on our Form 6-K, as applicable.
Read in the reply
Year Ended 31 March 2012 Compared to Year Ended 31 March 2011, page 89 · Income tax benefit (expense), page 93
SEC asked (2)
We note your response to comment two from our letter dated January 9, 2013. In your proposed disclosure, you indicate that the U.S. GAAP effective tax rate is not meaningful as it was favorably impacted by RCI’s successful appeal of the ATO’s disputed 1999 amended tax assessment. Please ensure that you discuss your U.S.
Rest of the question

GAAP effective tax rate in the same manner as your comparable non-GAAP financial measure and that your corresponding disclosures do not place more prominence on the non-GAAP financial measures. Refer to Item 10(e) of Regulation S-K.

JHX answered
We note the Staff’s comment regarding the discussion of the U.S. GAAP effective tax rate as set forth in our proposed disclosure in our response letter to the Staff dated February 25, 2013. As discussed with the Staff in a telephone exchange on March 25, 2013, the Company will also amend its disclosures in future filings to discuss changes in our U.S.
Rest of the answer

GAAP effective tax rate in a manner that does not place more prominence on the corresponding non-GAAP financial measure.

The following is an example of the anticipated revision to our future disclosure based on page 93 of our Form 20-F:

The Company’s effective tax benefit rate was 299.9% in fiscal year 2012, compared to an effective income tax expense rate of 459.2% in fiscal year 2011. The effective tax benefit rate in fiscal year 2012 was materially impacted by RCI’s successful appeal of the

ATO’s disputed 1999 amended tax assessment, resulting in an income tax benefit of US$485.2 million, compared to an income tax expense of US$345.2 million in fiscal year 2011, as further discussed below. The Company’s effective tax benefit rate in fiscal year 2012 was also impacted by unfavourable asbestos adjustments of

US$15.8 million, compared to US$85.8 million in the prior year, and an asset impairment charge of US$14.3 million, compared to nil in the prior year.

The Company’s effective tax rate excluding asbestos, asset impairments and tax adjustments was 22.9% in fiscal year 2012, compared to

31.1% in fiscal year 2011, due to a higher proportion of taxable income in jurisdictions with lower statutory income tax rates. The Company’s geographic mix of earnings and expenses is also affected by fluctuations in foreign currency exchange rates of the US dollar to relevant local jurisdiction currencies.

Read in the reply
Form 6-K Filed November 16, 2012 · Exhibit 99.2
SEC asked (3)
We note your response to comment five from our letter dated January 9, 2013. With regard to the quantitative reconciliation of non-GAAP financial measures that are forward-looking, Regulation G requires a schedule or other presentation detailing the differences between the forward-looking non-GAAP financial measure and the appropriate forward-looking GAAP financial measure.
Rest of the question

If the GAAP financial measure is not accessible on a forward-looking basis, you should disclose that fact and provide reconciling information that is available without an unreasonable effort. Furthermore, you should identify information that is unavailable and disclose its probable significance. Please revise your disclosures accordingly. Refer to SEC Release No. 33-8176.

JHX answered
Staff’s comment seeking a quantitative reconciliation of our non-GAAP forward-looking financial measure to the appropriate forward-looking GAAP financial measure.

As discussed with the Staff in a telephone exchange on March 25, 2013, we are unable to determine, without unreasonable effort, the effect that asbestos adjustments will have on the most directly comparable forward-looking U.S. GAAP financial measure, being forecasted net income (net operating profit).
Rest of the answer

Since asbestos-related assets and liabilities are denominated in Australian dollars, asbestos adjustments, together with their tax effect, as applicable, reflect the impact on our earnings arising from movements in foreign currency exchange rates as well as changes in actuarial estimates.

Either or both of these uncertainties can materially impact our earnings. For example, within the preceding five fiscal years, the Company’s asbestos adjustments have ranged from favourable asbestos adjustments of US$17.4 million in fiscal year 2009 to unfavourable asbestos adjustments of US$224.2 million in fiscal year 2010. In addition, while our non-GAAP forward-looking financial measure assumes an average exchange rate, we are unable to reasonably determine, on a forward-looking basis, the extent to which our full year earnings will be impacted by movements in foreign currency exchange rates.

As a result, we are unable to forecast or adequately reconcile, without unreasonable effort, the most directly comparable U.S. GAAP forward-looking financial measure.

Accordingly, in future filings, the Company will indicate that it is unable to provide, without unreasonable effort, the most directly comparable U.S. GAAP forward-looking financial measure, due to material uncertainties regarding the impact to earnings in future periods of asbestos adjustments, which include foreign currency exchange rates and changes in actuarial adjustments. The following is an example of the anticipated revision to our future disclosure based on page 5 of Exhibit 99.2 (Media Release) of our Form 6-K dated November 16, 2012:

Full Year

Earnings Guidance

Management expects full year earnings excluding asbestos, ASIC expenses and tax adjustments to be between US$140 million and US$150 million assuming, among other things, housing industry conditions in the United States continue to improve, the accounting provision for New Zealand product liability expenses remains adequate and that an average exchange rate of approximately US$1.04/A$1.00 applies for the balance of the year ending 31 March 2013.

The company is unable to forecast the most directly comparable U.S. GAAP forward-looking financial measure due to material uncertainties regarding the extent to which the company’s earnings will be impacted by asbestos adjustments, which include fluctuations in foreign currency exchange rates and changes in actuarial adjustments, together with their related tax effect, as applicable. These uncertainties may have a material impact on the company’s forecast full year earnings.

Read in the reply
Exhibit 99.3
SEC asked (4)
We note your response to comment six from our letter dated January 9, 2013. Given that the description operating profit before income taxes could be viewed to be confusingly similar to your operating income line item presented in your US GAAP financial statements and Rule 5-03 of Regulation S-X would imply that items such as interest expense and interest income would not generally be included in the determination of
Rest of the question

operating income or profit, please help us better understand how you determined your current presentation of operating profit before income taxes is appropriate. Please also tell us what consideration you gave to changing the description of the line item currently described as EBIT to operating income to be consistent with the financial statements provided in your Form 20-F for the year ended March 31, 2012 as well as the financial statements provided in Exhibit 99.5 of this Form 6-K.

JHX answered
We note the Staff’s comment regarding line item descriptions used in our Form

6-K. We supplementally advise the Staff that as a foreign incorporated entity listed on the Australian Securities Exchange (“ASX”), we are subject to ASX listing rules and Australian law regarding continuous and periodic disclosure. These disclosure requirements require us to lodge with the ASX, on a regular basis, a review of our results of operations.
Rest of the answer

Accordingly, to meet our reporting requirements to the ASX and as required by Australian law, we lodge with the ASX a

“Management’s Analysis of Results”, together with our financial statements, and furnish this information in a Form 6-K under our continuous disclosure requirements in the United States.

As the majority of our security holders are resident in Australia, and in light of our reporting requirements under ASX listing rules and Australian law, we use line item descriptions applicable to our reporting requirements in Australia in the review of our results of operations.

To align the review of our results of operations, as contained within Management’s Analysis of Results, with our financial statements, we have provided a “Definitions” section which cross-references the Australian line item descriptions to the corresponding U.S. GAAP descriptions in our financial statements.

As discussed with the Staff, we will provide additional clarification on the terminology differences in future Form 6-K reports (beginning with the Company’s Form 6-K, which we expect to furnish on May 22, 2013), and amend the “Definitions” section as follows in Exhibits 99.2 and 99.3:

Financial Measures

This document contains financial statement line item descriptions that are considered to be non-U.S. GAAP, but are consistent with those used by Australian companies. Because the company prepares its consolidated financial statements under U.S. GAAP, the following table cross-references each non-U.S. GAAP line item description, as used in Management’s Analysis of Results and Media Release, to the equivalent U.S. GAAP financial statement line item description used in the company’s consolidated financial statements:

Management’s Analysis of Results and Media Release

Consolidated Statements of Operations

(US GAAP)

Net sales

Cost of goods sold

Gross profit

Selling, general and administrative expenses

Research and development expenses

Asbestos adjustments

EBIT *

Operating income (loss)

Net interest (expense) income *

Sum of interest expense and interest income

Other income (expense)

Operating profit (loss) before income taxes *

Income (loss) before income taxes

Income tax expense

Net operating profit (loss) *

Net income (loss)

*

Represents non-US GAAP descriptions used by Australian companies.

Read in the reply
Exhibit 99.3
SEC asked (5)
We note your response to comment seven from our letter dated January 9, 2013. We continue to have difficulty understanding how you determined it was appropriate to present full non-GAAP financial statements for purposes of reconciling non-GAAP measures to the most directly comparable U.S. GAAP measures.
Rest of the question

Please revise your presentation to provide relevant information to investors without providing full non-GAAP financial statements. Alternatively, you may consider including summary financial information rather than full non-GAAP financial statements. For additional guidance, please refer to Compliance and Disclosures Interpretation 102.10 which is available on our website at http://www.sec.gov/divisions/corpfin/guidance/nongaapinterp.htm.

JHX answered
We note the Staff’s comment regarding the presentation of full non-GAAP financial statements for purposes of reconciling non-GAAP measures to the most directly comparable U.S. GAAP measures. As discussed with the Staff, we will remove the full non-GAAP financial statements in future Form

6-K reports. Instead, we will present a summary of selected financial information in order to disclose the relevant information to users of our financial statements regarding the impact of asbestos on our consolidated financial position and results of operations.
Rest of the answer

The following is an example of the anticipated revision to our disclosure in Exhibit 99.3:

Supplemental

Financial Information

As set forth in Note 7 of the 30 September 2012 Condensed Consolidated Financial Statements, the net AFFA liability, while recurring, is based on periodic actuarial determinations, claims experience and currency fluctuations. The company’s management measures its financial position, operating performance and year-over-year changes in operating results with and without the effect of the net AFFA liability. Accordingly, management believes that the following non-GAAP information is useful to it and investors in evaluating the company’s financial position and ongoing operating financial performance. The following non-GAAP table should be read in conjunction with JHI plc’s consolidated financial statements and related notes contained in the company’s 30 September 2012 Condensed Consolidated Financial

Statements.

Supplementary Financial Information

30 September 2012

(Unaudited)

(Millions of US dollars)

Total Fibre

Cement –

Excluding

Asbestos

Compensation

Reported

Restricted cash and cash equivalents – Asbestos

$

—

63.2

Restricted short-term investments – Asbestos

116.8

Insurance receivable – Asbestos¹

209.0

Workers compensation asset – Asbestos¹

84.4

Deferred income taxes – Asbestos¹

431.6

Asbestos liability¹

1,601.3

Workers compensation liability – Asbestos¹

Income taxes payable

17.2

(13.1

)

4.1

Favourable asbestos adjustments

2.8

(100.2

(0.7

(100.9

Net interest (expense) income

(2.0

2.2

0.2

(20.1

(2.6

(22.7

¹

The amounts shown on these lines are a summation of both the current and non-current portion of the respective asset or liability as presented on the company’s

Condensed Consolidated Balance Sheets.

Read in the reply
Form 6-K Filed March 1, 2013 · Exhibit 99.5
SEC asked (6)
During the nine months ended December 31, 2012, you recorded a provision related to New Zealand product liability claims of $13.2 million which represented approximately 10% of your operating income for this period. You are becoming exposed to liability for a greater proportion of these claims due to the insolvency of co-defendants and the expiration of some of your rights of recovery from third-parties.
Rest of the question

In this regard, please address the following:  You disclose the amount of provision for product liability claims, net of estimated thirdparty recoveries, is $16.5 million at December 31, 2012. Please also disclose the corresponding gross asset and liability amounts recorded for your provision for product liability claims and estimated third-party recoveries; and  If there is at least a reasonable possibility that a loss exceeding amounts already recognized may have been incurred, please either disclose an estimate (or, if true, state that the estimate is immaterial in lieu of providing quantified amounts) of the additional loss or range of loss, or state that such an estimate cannot be made. Please refer to ASC 450-20-50. If you conclude that you cannot estimate the reasonably possible additional loss or range of loss, please supplementally: (1) explain to us the procedures you undertake on a quarterly basis to attempt to develop a range of reasonably possible loss for disclosure and (2) what specific factors are causing the inability to estimate and when you expect those factors to be alleviated. We recognize that there are a number of uncertainties and potential outcomes associated with loss contingencies. Nonetheless, an effort should be made to develop estimates for purposes of disclosure, including determining which of the potential outcomes are reasonably possible and what the reasonably possible range of losses would be for those reasonably possible outcomes.

JHX answered
recognition and disclosure of our product liability claims in New Zealand. We have recovered and continue to recover costs associated with defending and resolving a portion of these claims under third-party contractual rights. While the expiration of our contractual rights has become increasingly relevant, these recoveries continue to mitigate our total estimated losses. Accordingly, a portion of the losses we incur that are reflected in our earnings are mitigated to the extent that such losses are recoverable under contractual rights.
Rest of the answer

Accordingly, as discussed with the Staff, we believe that our current disclosure of the liability, net of third party recoveries, appropriately conveys the company’s exposure associated with defending and resolving such claims in the future. We believe that disclosing this amount, together with the amount of expense incurred in defending and resolving such claims, prevents the financial statements from being misleading.

In addition, we have noted in our disclosure that the amount of estimated loss is dependent on a number of factors including, without limitation, the specific facts and circumstances unique to each claim brought against the Company, the existence of any co-defendants involved in defending the claim, the solvency of such co-defendants (including the ability of such co-defendants to remain solvent until the related claim is ultimately resolved), the availability of claimant compensation under a Government compensation scheme, the amount of loss estimated to be allocable to the Company in instances that involve co-defendants in defending the claim and the extent to which the Company has access to third-party recoveries to cover a portion of the costs incurred in defending and resolving such actions. In addition to the above limitations, the total loss incurred is also dependent on the manner and extent to which the statute of limitations will apply in future periods.

While we regularly review our assumptions to estimate the amount of loss for both asserted and unasserted claims, we acknowledge that it is reasonably possible that actual losses may be in excess of amounts already accrued as of December 31, 2012. Accordingly, we will expand our disclosure to include an estimate of potential losses, beyond amounts already accrued, that may be incurred in future periods.

For example, in addition to our current disclosure, the following additional information is expected to be included in our future disclosure, based on pages F-20 and F-21 of Exhibit 99.5 of our Form 6-K:

The

Company has made a provision for asserted and unasserted New Zealand product liability claims within Other Current and Other Non-current Liabilities, with a corresponding estimated receivable for third-party recoveries being recognised within

Accounts and Other Receivables at 31 December 2012. The amount of provision for product liability claims in New Zealand, net of estimated third-party recoveries, is US$16.5 million at 31 December 2012. During the nine months ended

31 December 2012, the Company recognised US$13.2 million in expenses related to the legacy New Zealand product liability claims.

The Company’s estimated loss incorporates assumptions that are subject to the foregoing uncertainties and are principally derived from, but not exclusively based on, historical claims experience. If the nature and extent of claims in future periods differ from the Company’s historical claims experience, then the actual amount of loss may be materially higher or lower than estimated losses accrued at 31 December 2012. For example, despite having resolved a number of legacy product liability claims in New Zealand since 2002, the Company is becoming exposed to increased losses for a greater proportion of these claims due to the insolvency of co-defendants and the expiration of some of the Company’s rights of third-party recoveries. Accordingly, due to the inherent uncertainties associated with estimating the amount of loss incurred for asserted and unasserted claims, as discussed above, and based on information presently available, the Company believes it is possible that the ultimate resolution of these legacy claims could result in an additional loss of up to approximately US$10 million in excess of the amount accrued, net of estimated third-party recoveries, at 31 December 2012. Accordingly, losses incurred in connection with defending and resolving asserted and unasserted New Zealand product liability claims in the future could have a material adverse effect on the Company’s financial position, liquidity, results of operations and cash flows.

* * * *

You may call the undersigned with any questions or comments you may have regarding this letter at (312) 705-6192. In addition, please send all written correspondence directly to the undersigned, with copies to James J. Moloney of Gibson, Dunn & Crutcher LLP, 3161 Michelson Drive, Irvine, California 92612, facsimile (949) 475-4756.

Read in the reply

Also in this review: request for more time, Jan 24, 2013, company letter, Mar 25, 2013, closing letter, 2013-04-15

Form 20-F for the Year Ended March 31, 2011

2012-02-03 to 2012-03-07 · 3 questions · 1 letter from the SEC, 1 from the company
Review closed 2012-03-07
Liquidity and cashLegal and contingenciesGoodwill and impairmentResults discussion (MD&A)
General
SEC asked (1)
Where a comment below requests additional disclosures or other revisions to be made, please show us in your supplemental response what the revisions will look like. These revisions should be included in your future filings, including your interim filings, if applicable.
JHX answered
We acknowledge your comment and will provide additional disclosures or other revisions supplementally as requested. We have included such revisions, as applicable, in our disclosures to the condensed consolidated financial statements as of and for the period ended December 31, 2011, which was furnished to the SEC on Form 6-K on March 1, 2012. We will also include such revisions in our future filings.

Mr. Rufus Decker

Financial Statements

Summary of Significant Accounting Policies, page 80

Impairment of Long-Lived Assets,
Read in the reply
Summary of Significant Accounting Policies, page 80 · Impairment of Long-Lived Assets, page 80
SEC asked (2)
We note your disclosures regarding impairment of long-lived assets. In the interest of providing readers with a better insight into management’s judgments in accounting for longlived assets, including property and equipment and customer relationships intangible assets, please disclose the following:  How you group long-lived assets for impairment and your basis for that determination;  How frequently you evaluate
Rest of the question

for the types of events and circumstances that may indicate impairment;  Sufficient information to enable a reader to understand how you determine fair value; and  The carrying value of any long-lived assets or asset groups for which the carrying value is close to corresponding undiscounted cash flows or fair value. 15. Commitment and Contingencies, page 94

JHX answered
We note the Staff’s comment seeking clarification on management’s judgments used in accounting for long-lived assets. We supplementally advise the Staff that, as of March 31, 2011, no events or circumstances were identified by the Company that indicate the carrying value of long-lived assets might not be recoverable.

In addition, we supplementally advise the Staff that the Company’s long-lived assets do not include customer relationships or other intangible assets. The Company routinely assesses its property and equipment long-lived assets on a quarterly basis for impairment indicators.
Rest of the answer

The Company has implemented internal controls and processes to assist in the detection of such impairment indicators. We supplementally advise the Staff that in the future, should the Company identify any events or circumstances that indicate the carrying value of long-lived assets might not be recoverable, the Company will disclose the information called for by the Staff above.

In circumstances where the carrying value of any of the

Company’s long-lived assets or asset groups approximates the corresponding undiscounted future cash flows or estimated fair value, the Company will disclose such carrying values. We supplementally advise the Staff that as of March 31, 2011, the Company does not have any long-lived assets with carrying values that approximate the corresponding undiscounted cash flows or estimated fair values. Accordingly, we do not believe any revisions or expanded disclosures are required in future filings in response to the Staff’s comment in this regard, until such conditions become applicable to the Company.

The following is an example of the anticipated revisions to our future disclosure based on the accounting policy for impairment of long-lived assets on page 80 of the Form 20-F:

Long-lived assets, such as property, plant and equipment, are evaluated each quarter for events or changes in circumstances that indicate that an asset might be impaired because the carrying amount of the asset may not be recoverable. These include, without limitation, a significant adverse change in the extent or manner in which a long-lived asset or asset group is being used, a current period operating or cash flow loss combined with a history of operating or cash flow losses, a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset or asset group and/or a current expectation that it is more likely than not that a long lived asset or asset group will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.

When such indicators of potential impairment are identified, recoverability is tested by grouping long-lived assets that are used together and represent the lowest level for which cash flows are identifiable and distinct from the cash flows of other long-lived assets, which is typically at the production line or plant facility level, depending on the type of long-lived asset subject to an impairment review.

Recoverability is measured by a comparison of the carrying amount of the asset group to the estimated undiscounted future cash flows expected to be generated by the asset group. If the carrying amount exceeds the estimated undiscounted future cash flows, an impairment charge is recognized at the amount by which the carrying amount exceeds the estimated fair value of the asset group.

The methodology used to estimate the fair value of the asset group is based on a discounted cash flow analysis that considers the asset group’s highest and best use that would maximize the value of the asset group. In addition, the estimated fair value of an asset group also considers, to the extent practicable, a market participant’s expectations and assumptions in estimating the fair value of the asset group. If the estimated fair value of the asset group is less than the carrying value, an impairment loss is recognized at an amount equal to the excess of the carrying value over the estimated fair value of the asset group.

15. Commitment and Contingencies, page 94

Read in the reply
ASIC Proceedings, page 94
SEC asked (3)
You disclosed that on December 17, 2010, you were ordered to pay 90% of the costs incurred by AISC in respect of your appeal. You also disclose in MD&A that you were ordered to pay a portion of the costs for each of the first instance proceedings and appeal. You indicated that in light of the uncertainty surrounding the amount of such costs, you have not recorded any provisions for these costs at March 31, 2011.
Rest of the question

Please clarify whether ASIC has provided you with the amount of costs that they incurred. You also disclose that losses and expenses arising from the ASIC proceedings could have a material adverse effect on your financial position, liquidity, results of operations and cash flows. If there is at least a reasonable possibility that a loss exceeding amounts already recognized may have been incurred for your ASIC matter, please either disclose an estimate (or, if true, state that the estimate is immaterial in lieu of providing quantified amounts) of the additional loss or range of loss, or state that such an estimate cannot be made. Please refer to ASC 450-20-50.

JHX answered
We note the Staff’s comment and supplementally advise the Staff that ASIC has not provided the Company with the amount of costs it has incurred in connection with the ASIC Proceedings. In addition, we supplementally advise the Staff that in light of the inherent uncertainty surrounding the amount of such costs, the Company is currently unable to estimate the additional loss or range of loss relating to the quantum of costs incurred by ASIC.

In future filings (including our quarterly results furnished to the SEC on Form 6-K on March 1, 2012), the disclosure on page 94 of the Form 20-F will be
Rest of the answer

enhanced as follows with respect to the costs that the Company may be required to pay to ASIC:

The amount of the costs that the Company may be required to pay to ASIC following the Court of Appeal judgments is contingent on a number of factors. These include, without limitation, whether such costs (including the costs orders in ASIC’s favor against the Company in the first instance hearing, which orders were not disturbed by the Court of Appeal) are reasonable having regard to the issues pursued in the case by ASIC against the Company, the number of legal practitioners involved in such legal work and their applicable fee rates. In addition, the amount of costs is contingent on the associated legal work undertaken specifically in respect of those issues, since the Company is not liable for legal costs of a previous claim and related order that was withdrawn by ASIC in September 2008, the overlapping claims against other parties in the first instance or appeal proceedings or the successful interlocutory appeal by the Company against ASIC during the course of the first instance hearing.

ASIC has not notified the Company of the amount of costs that it has incurred in connection with the ASIC Proceedings. In addition, any costs that may be asserted by ASIC in the future will be subject to third party review and may not represent the amount of costs the Company will ultimately be liable to pay. Accordingly, in light of the inherent uncertainty surrounding the amount of such costs, together with the unusual circumstances surrounding the ASIC proceedings, the Company is unable to estimate the additional loss or range of loss relating to the quantum of costs incurred by

ASIC at this time. Therefore, the Company has not recorded any provision for these costs at March 31, 2011.

* * * *

You may call the undersigned with any questions or comments you may have regarding this letter at (312) 705-6192. In addition, please send all written correspondence directly to the undersigned, with copies to James J. Moloney of Gibson, Dunn & Crutcher LLP, 3161 Michelson Drive, Irvine, California 92612, facsimile (949) 475-4756.

Read in the reply

Also in this review: request for more time, Feb 10, 2012, closing letter, 2012-03-07

Form F-4

2010-03-30 to 2010-03-30 · 2 questions · 1 letter from the SEC, 0 from the company
No closing letter
SEC letter of Mar 30, 2010 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Prospectus Cover Page
SEC asked (1)
Please revise the cover to indicate that shareholders will continue to hold the same number of CUFS or ADSs in Irish SE if Stage 2 is appoved.
JHX answered

No reply letter found.

Letter from the Chairmen
SEC asked (2)
Clearly indicate the changes to the proposed articles of associaton for Irish SE that resulted from your review of comments from investor advisory groups. Matters that you reviewed and declined to implement should also be highlighted in the Chairmen’s letter. * * * As appropriate, please amend your registration statement in response to these comments.
Rest of the question

You may wish to provide us with marked copies of the amendment to expedite our review. Please furnish a cover letter with your amendment that keys your responses to our comments and provides any requested information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing your amendment and responses to our comments. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes all information required under the Securities Act of 1933 and that they have provided all information investors require for an informed investment decision. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made. Notwithstanding our comments, in the ev ent the company requests acceleration of the effective date of the pending registration statement, it should furnish a letter, at the time of such request, acknowledging that: • should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. In addition, please be advi sed that the Division of Enforcement has access to all information you provide to the staff of the Division of Corporation Finance in connection with our review of your filing or in response to our comments on your filing. We will consider a written request for acceleration of the effective date of the registration statement as confirmation of the fact that those requesting acceleration are aware of their respective responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the securities specified in the above registration statement. We will act on the request and, pursuant to delegated authority, grant acceleration of the effective date. We direct your attention to Rules 460 and 461 regarding requesting acceleration of a registration statement. Please allow adequate time after the filing of any amendment for further review before submitting a request for acceleration. Please provide this request at least two business days in advance of the requested effective date. You may contact me at (202) 551-3397 with any questions.

JHX answered

No reply letter found.

Form 20-F for the fiscal year ended March 31, 2009

2009-11-04 to 2010-01-05 · 22 questions · 2 letters from the SEC, 2 from the company
Review closed 2010-01-05
Liquidity and cashNon-GAAP measuresResults discussion (MD&A)DebtGoodwill and impairmentCritical estimatesSegmentsInventoryPensionsControlsLegal and contingenciesIncome taxes
Item 3 – Key Information, page 2 · Selected Financial Data, page 2
SEC asked (1)
We note that you are excluding loss from discontinued operations, non-operating expenses and cumulative effect of change in accounting principle from EBITDA. Question 14 of our FAQ Regarding the Use of Non-GAAP Financial Measures dated June 13, 2003 clearly states that EBITDA is defined as “earnings before interest, taxes, depreciation and amortization.” Earnings is intended to mean net income rather than income
Rest of the question

from continuing operations. To the extent EBITDA is not computed as commonly defined, please revise the title you use in future filings so that it conveys this. One choice may be to call it adjusted EBITDA.

JHX answered
We note the Staff’s comment and will revise the title to “Adjusted EBITDA” in our future filings to the extent EBITDA is not computed as commonly defined.
Read in the reply
Item 4 - Information on the Company, page 24 · History and Development of the Company, page 24
SEC asked (2)
In future filings, please disclose the legislation under which the Company operates. See Item 4.A.3 of Form 20-F.
JHX answered
We note the Staff’s comment seeking disclosure of the legislation under which the Company operates. We respectfully submit that the Company has disclosed in the 20-F the legislation under which it currently operates. Specifically, on page 24 of the 20-F, the Company states that it “operates under Dutch law.” Also, as disclosed on page 6 of the 20-F and in the

Company’s Registration Statement on Form F-4 (File Number 333-160177) (the “F-4”), we are in the process of transforming the Company into a European Company (Societas Europaea (“SE”)) and transferring the Company’s corporate domicile
Rest of the answer

from The Netherlands to Ireland (See page

7 of the F-4). If and when the Company’s corporate domicile is successfully transferred to

Ireland, it will operate under Irish law. Until such time, the Company will continue to operate under Dutch law. Furthermore, upon transformation to an SE, the Company also will be subject to European Union Council Regulations and relevant European Union Directives in addition to Dutch or Irish law, as applicable.

Read in the reply
Dependence on Trade Secrets and Research and Development, page 35
SEC asked (3)
In future filings, please disclose the extent to which the Company is dependent on patents or licenses; industrial, commercial or financial contracts; or new manufacturing processes. See Item 4.B.6 of Form 20-F.
JHX answered
We note the Staff’s comment seeking disclosure of the extent to which the Company is dependent on patents or licenses; industrial, commercial or financial contracts; or new manufacturing processes. As disclosed on pages 19, 20, 33, 35, 50 and 67 of the 20-F, the

Company has a variety of patents and licenses; industrial, commercial and financial contracts; and manufacturing processes.
Rest of the answer

The Company will include the following disclosure to clarify its dependence on patents, licenses; industrial, commercial or financial contracts; or new manufacturing processes in future filings on Form

20-F:

The Company has a variety of patents and licenses; industrial, commercial and financial contracts; and manufacturing processes. While the

Company is dependent on the competitive advantage that these items provide as a whole, the Company is not dependent on any one of them individually and does not consider any one of them individually to be material.

Read in the reply
Government Regulation, page 36
SEC asked (4)
In future filings, please clearly describe the material effects of government regulations on the Company’s business and identify the applicable regulatory body. See Item 4.B.8 of Form 20-F.
JHX answered
We note the Staff’s comment requesting that we clearly describe the material effects of government regulations on the Company’s business and identify the applicable regulatory body. Similar to many other multinational corporations that own assets, manufacture and sell products in numerous countries around the world, the Company is subject to many regulations in numerous jurisdictions, including, without limitation, the Dutch Authority Financial

Markets, the Australian Securities Exchange (“ASX”), the Australian Securities and

Investments Commission (“ASIC”), James Hardie (Civil Liability)
Rest of the answer

Act 2005 (NSW), James Hardie

(Civil Penalty Compensation Release) Act 2005 (NSW), James Hardie (Winding up and

Administration) Act 2005 (NSW), the U.S. Securities and Exchange Commission (“SEC”), the New

York Stock Exchange (“NYSE”), U.S. environmental regulations and U.S. health and safety regulations. Furthermore, upon transformation to an SE, the Company also will be subject to

European Union Council regulations and relevant European Union Directives. While these regulations generally affect the Company’s business, none of them individually stands out as more material than any other government regulation. As noted above in our response to comment 2, if the Company is successful in transferring its corporate domicile to Ireland, the Company will become subject to a variety of Irish regulations (See page 36 of the F-4 for a summary of the features of Irish company law) and will describe, to the extent material, the Irish regulations to which the Company is subject in its next Form 20-F.

Read in the reply
Critical Accounting Policies, page 51 · General
SEC asked (5)
You recorded impairment charges of $71.0 million for the year ended March 31, 2008. To the extent that any of your long-lived assets or asset groups have estimated fair values that are not substantially in excess of the carrying values and to the extent that the asset amounts, in the aggregate or individually, could materially impact your operating results or total shareholder’s equity, please provide the following
Rest of the question

disclosures in future filings: • The percentage by which fair value exceeds the carrying value as of the mostrecent test; • A description of the assumptions that drive the estimated fair value; • A discussion of the uncertainty associated with the key assumptions. For example, to the extent that you have included assumptions that materially deviate from your historical results, please include a discussion of these assumptions; and • A discussion of any potential events and/or circumstances that could have a negative effect to the estimated fair value. Please refer to Item 303 of Regulation S-K and Sections 216 and 501.14 of the Financial Reporting Codification for guidance. Please show us in your supplemental response what the revisions will look like.

JHX answered
We note the Staff’s comment and, in future filings on Form 20-F, the Company will provide the disclosures indicated above, to the extent that any of our long-lived assets or asset groups have estimated fair values that are not substantially in excess of the carrying values and to the extent that the asset amounts, in the aggregate or individually, could materially impact our operating results or total shareholder’s equity.
Rest of the answer

We supplementally advise the Staff that as of March 31, 2009, none of our long-lived assets or asset groups have estimated fair values that were not substantially in excess of the carrying values and accordingly, do not believe any revisions of the 20-F disclosure would be required in future filings in response to the Staff’s comment.

Read in the reply
Results of Operations, page 54
SEC asked (6)
In future filings, please discuss in greater detail the business reasons for the changes between periods in gross profit of each of your segments. In doing so, please disclose the amount of each significant change between periods and the business reasons for it.
Rest of the question

In circumstances where there is more than one business reason for the change, attempt to quantify the incremental impact of each individual business reason discussed on the overall change. For example, you should discuss the impact on gross profit that fluctuations in the cost of raw materials necessary to your business had as discussed on page 18. See Item 303(a)(3) of Regulation S-K. Please show us in your supplemental response what the revisions will look like.

JHX answered
We note the Staff’s comment seeking disclosure of the business reasons for the changes between periods in gross profit of each of our segments. We respectfully submit that the

Company has disclosed, on page 56 of the 20-F, business reasons for the changes between periods and the business reasons for it.

However, based on the Staff’s comment, the Company will provide additional disclosure in our gross profit discussion in future filings (beginning with our third quarter ended December

31, 2009 results, which will be furnished via Form 6-K) to further explain the significant business reasons
Rest of the answer

for changes in our gross profit in each segment.

The following is an example of what the revisions will look like based on the 20-F page 56 for our USA and Europe Fiber Cement segment:

USA and Europe Fiber Cement gross profit decreased 29% compared to fiscal year 2008 due to lower sales volume (21%) and higher average unit manufacturing costs (8%). The higher average unit manufacturing costs were the result of fixed costs being absorbed over significantly reduced volumes. The gross profit margin of our USA and Europe Fiber

Cement business decreased 4.1 percentage points in fiscal year 2009.

Read in the reply
Liquidity and Capital Resources, page 64
SEC asked (7)
Your disclosures indicate that you fund your working capital needs and capital expenditure requirements through a combination of cash flow from operations, proceeds from the divestiture of businesses, credit facilities and other borrowings, proceeds from the sale of PP&E, and proceeds from the redemption of investments.
Rest of the question

Please further enhance your disclosures in future filings to discuss significant changes in your expected sources and uses of cash from period to period and the impact of these changes on your liquidity and capital resources. In this regard, we note that significant cash flows from your credit facilities have been required to fund your working capital needs and capital expenditure requirements. We also note that net operating cash flows moved from a cash inflow to a cash outflow in fiscal year 2009. When there are significant changes in the sources and uses of cash such as the decrease in cash flow from operations, please advise how you determined that the sources will continue to be sufficient to meet your needs. Please show us in your supplemental response what the revisions will look like.

JHX answered
We note the Staff’s comment and will revise our future filings (beginning with our third quarter ended December 31, 2009 results, which will be furnished via Form 6-K) to discuss significant changes in our expected sources and uses of cash from period to period and the impact of these changes on our liquidity and capital resources.
Rest of the answer

When there are significant changes in the sources and uses of cash, we will discuss how we determined that the sources will continue to be sufficient to meet our needs.

The following is an example of the additional disclosure that will be added in the Liquidity and Capital Resources section in our future filings:

During fiscal year 2009, there were two significant cash outflows which caused net operating cash flow to be negative: the payment to the AICF of $110.0 million and the ATO settlement payment of $101.6 million. These two significant cash outflows resulted in the need for cash to be provided by financing activities of $25.0 million, which differed from fiscal years 2008 and 2007 where cash was used in financing activities, totalling $254.4 million and $136.4 million, respectively.

Historically, the Company has generated cash from operations, before accounting for unusual or discrete large cash outflows. Therefore, in years when the Company does not incur any unusual or discrete large cash outflows, similar to the ATO settlement in fiscal year 2009 and the deposit with the Australian Taxation Office in fiscal year 2007, the Company expects that net operating cash flows will be the primary source of liquidity to fund business activities. In years where cash flows from operations are insufficient to fund all business activities, the Company expects to rely more significantly on availability under credit facilities and other sources of working capital.

Read in the reply
Liquidity and Capital Resources, page 64
SEC asked (8)
We note your credit facility agreements contain covenants that require you to maintain certain ratios, among other restrictions. For each class of debt, please ensure that you clearly disclose in future filings the specific terms of any material debt covenants and whether you were in compliance with the covenants as of the reporting date.
Rest of the question

In addition, if it is reasonably likely that you will not be in compliance with any of your material debt covenants, please disclose the required ratios/amounts as well as the actual ratios/amounts as of each reporting date. This will allow readers to understand how much cushion there is between the required ratios/amounts and the actual ratios/amounts. Please also consider showing the specific computations used to arrive at the actual ratios/amounts. See Sections I.D and IV.C of the SEC Interpretive Release No. 33-8350 and Question 10 of our FAQ Regarding the Use of Non-GAAP Financial Measures dated June 13, 2003. Please show us in your supplemental response what the revisions will look like.

JHX answered
We note the Staff’s comment to clearly disclose the specific terms of any material debt covenants and whether we were in compliance with the covenants as of the reporting date. We respectfully submit that the Company has disclosed the terms of all material debt covenants on page 65 of the 20-F.

In addition, the Company determined at the reporting date that it was reasonably likely that it would be in compliance with our material debt covenants within at least the next 12 months. As a result, no additional disclosures were provided in the 20-F.
Read in the reply
Liquidity and Capital Resources, page 64
SEC asked (9)
Please expand your disclosure in future filings to discuss all material changes in your operating activities as depicted in your statement of cash flows, including the changes in accounts and notes receivable, inventories, and accounts payable and accrued liabilities. Please show us in your supplemental response what the
JHX answered
all material changes in our operating activities as depicted in our statement of cash flows.

The following is an example of what our revised disclosure will look like:

Net operating cash moved from a cash inflow of $319.3 million in fiscal year 2008 to a cash outflow of $45.2 million in fiscal year

2009, primarily due to the ATO settlement payment of $101.6 million, the quarterly installment payments to the AICF totaling $110.0 million and the reduced contribution from the USA and Europe Fiber Cement business.
Rest of the answer

Our net operating cash flow also was negatively impacted by changes in our operating assets and liabilities, primarily due to changes in our other accrued liabilities and other liabilities, asbestos liability and accounts receivable, which were partially offset by a decrease in our inventory primarily as a result of lower sales and a greater focus on reducing inventory days on hand in the

USA and Europe Fiber Cement segment. See Note 14 to our notes to our consolidated financial statements included in Item 18 for more information on the ATO settlement.

Read in the reply
Contractual Obligations, page 68
SEC asked (10)
Please revise your table of contractual obligations in future filings to include the following: • Estimated interest payments on your debt, and • Planned or required payments to fund pensions and other post-employment benefits Because the table is aimed at increasing transparency of cash flow, we believe these payments should be included in the table.
Rest of the question

Please also disclose any assumptions you made to derive these amounts. Please show us in your supplemental response what the revisions will look like.

JHX answered
In future filings on Form 20-F, the Company will revise our contractual obligations table to include estimated interest payments on our debt. The Company did not include and does not plan on including its post-employment benefit obligation in the contractual obligations table as the Company considers it to be immaterial.
Rest of the answer

Please see our related response to comment 14 below for additional details related to our defined benefit plan.

Contractual Obligations

The following table summarizes our contractual obligations at March 31, 2009:

Payments Due

During Fiscal Year Ending March 31,

(In millions)

Total

2010

2011 to

2012

2013 to

2014

Thereafter

Asbestos Liability

(1)

$

1,284.5

N/A

Long-Term Debt

230.7

—

Operating Leases

96.8

14.0

23.2

20.7

38.9

Interest (2)

XX.X

X.X

Purchase

Obligations (3)

0.6

1,612.6

14.6

253.9

The amount of the asbestos liability reflects the terms of the Amended FFA, which has been calculated by reference to (but is not exclusively based upon) the most recent actuarial estimate of the projected future asbestos-related cash flows prepared by KPMG Actuaries. The asbestos liability also includes an allowance for the future claims-handling costs of the AICF. The table above does not include a break down of payments due each year as such amounts are not reasonably estimable.

See Item 3, “Key Information — Risk Factors,” Item 4, “Information on the Company —

Commitment to Provide Funding on a Long-Term Basis in Respect of Asbestos-Related

Liabilities of Former Subsidiaries” and Note 11 of our consolidated financial statements in Item 18 for further information regarding our future obligations under the Amended FFA.

(2)

Interest amounts are estimates based on gross debt remaining unchanged from the

March 31, 2009 balance and interest rates remaining consistent with the fiscal year

2009 averages. Interest paid includes interest in relation to the Company’s debt facilities, as well as interest rate swap agreements. The interest on the Company’s debt facilities is variable based on a market rate and includes margins agreed to with the various lending banks. The interest on the Company’s interest rate swaps is set at a fixed rate. There are several variables that can affect the amount of interest the Company may pay in future years, including: (i) new debt facilities with rates or margins different from historical rates; (ii) expiration of existing debt facilities resulting in a change in the average interest rate; (iii) fluctuations in the market interest rate; (iv) new interest rate swap agreements;

and (v) expiration of existing interest rate swap agreements.

(3)

Purchase Obligations are defined as agreements to purchase goods or services that are enforceable and legally binding on us and that specify all significant terms, including: fixed or minimum quantities to be purchased; fixed, minimum or variable price provisions; and the approximate timing of the transactions.

Read in the reply
Item 6 - Directors, Senior Management and Employees, page 69
SEC asked (11)
In future filings, please provide the information required by Item 6.C.2 of Form 20-F relating to the provision of benefits for directors upon termination of employment or an appropriate negative statement.
JHX answered
The Company has letters of appointment for each Supervisory Board member. However, the

Company does not provide any benefits for our Supervisory Board directors upon termination of employment. In future filings on Form 20-F, we will provide an appropriate negative statement or the information required if we have such a provision.

The Company has disclosed details related to benefits upon termination for the Company’s

Managing Board members (comprising of our Chief Executive Officer, Chief Financial Officer and General Counsel) and certain other senior executives on pages 91 to 95 of the
Rest of the answer

20-F.

Read in the reply
Item 15 – Controls and Procedures, page 124
SEC asked (12)
Please disclose in future filings whether there have been any changes in your internal controls and procedures that occurred during the period covered by your annual report. Refer to paragraph (d) of Item 15 of Form 20-F.
JHX answered
We note the Staff’s comment and, in future filings on Form 20-F, we will disclose whether there have been any changes in our internal controls and procedures that occurred during the period covered by our annual report. We supplementally advise the Staff that in the annual period covered by the 20-F, there were no changes in our internal controls and procedures.

Item 18

– Financial Statements
Read in the reply
Item 18 - Financial Statements
SEC asked (13)
You disclose on page F-14 that you consider your interest in the AICF to be variable and you consolidate the AICF in accordance with FIN 46R. Please expand the notes to your financial statements in future filings to address the disclosure requirements set forth in paragraphs C4 and C5 of FSP FAS 140-4 and FIN 46(R)-8. Please show us in your supplemental response what the revisions will look like.
JHX answered
In future filings (beginning with our third quarter ended December 31, 2009 results, which will be furnished via Form 6-K), the Company will replace the AICF disclosure on page F-14 with the following:

In February 2007, the Company’s shareholders approved a proposal pursuant to which the Company provides long-term funding to the AICF.

The Company owns 100% of the Performing Subsidiary that funds the

AICF. Under the terms of the Amended FFA, the Performing Subsidiary has an obligation to make payments to the AICF on an annual basis, depending on our net operating cash flow.
Rest of the answer

The amounts of these annual payments are dependent on several factors, including our free cash flow (defined as cash from operations in accordance with GAAP in force at the date of the Original FFA), actuarial estimations, actual claims paid, operating expenses of the AICF and the annual cash flow cap. JHI

NV guarantees the Performing Subsidiary’s obligation. As a result, the

Company considers it to be the primary beneficiary of the AICF.

The Company’s interest in the AICF is considered variable because the potential impact on the Company will vary based upon the annual actuarial assessments obtained by the AICF with respect to asbestos-related personal injury claims against the Former James

Hardie Companies.

Although the Company has no legal ownership in the AICF, the Company consolidates the AICF due to its pecuniary and contractual interests in the AICF as a result of the funding arrangements outlined in the

Amended FFA.

As of March 31, 2009, the Company has not provided financial or other support to the AICF that it was not previously contractually required to provide. Future funding for the AICF continues to be linked under the terms of the Amended FFA to our long-term financial success, especially our ability to generate net operating cash flow.

The AICF has operating costs that are claims related and non-claims related. Claims related costs incurred by the AICF are treated as reductions to the accrued asbestos liability balances previously reflected in the consolidated balance sheets. Non-claims related operating costs incurred by the AICF are expensed as incurred in the line item Selling, general and administrative expenses in the consolidated statements of operations. The AICF earns interest on its cash and cash equivalents and on its short-term investments; these amounts are included in the line item Interest income in the consolidated statements of operations.

See Asbestos-Related Assets and Liabilities below and Note 11.

Asbestos for further details on the related assets and liabilities recorded in the Company’s consolidated balance sheet under the terms of the Amended FFA.

Read in the reply
Item 18 - Financial Statements
SEC asked (14)
You disclose on page F-12 that you sponsor both defined benefit and defined contribution retirement plans for your employees. Please expand your disclosure in future filings to meet the requirements of paragraphs 7 and E1 of SFAS 158 regarding your defined benefit plans.
Rest of the question

In addition, please disclose the amount of cost recognized for defined contribution retirement plans for all periods presented as required by paragraph 11 of SFAS 132R. Please show us in your supplemental response what the revisions will look like.

JHX answered
We note the Staff’s comment and supplementally advise the Staff that the defined benefit plan is no longer offered to our employees. There are only eight people in this plan and the annual expense associated with this plan is less than 1% of normalized earnings for each of the past three years. The Company considers the expense related to this plan immaterial and thus, no additional disclosure was required to be included by the Company.

Beginning with the Company’s annual report on Form 20-F for the fiscal year ended March 31,

2007, the Company no longer included the disclosure required by
Rest of the answer

paragraph 11 of SFAS 132R for its defined contribution plans as the Company had determined that the expense related to these plans were immaterial for purposes of disclosure. We supplementally advise the Staff that the Company’s expense for its defined contribution plans totaled $7.0 million, $8.9 million and $8.2 million for the years ended March 31, 2009, 2008 and 2007,

Read in the reply
Item 18 - Financial Statements
SEC asked (15)
We note your disclosure on page 39 that you suspended production at two of your plants in November 2008 and December 2008. As such, please tell us whether you determined that this was a triggering event that would require you to test long-lived assets for recoverability. If you concluded that this was not a triggering event, please elaborate. See paragraph 8 of SFAS 144.
JHX answered
We note the Staff’s comment and supplementally advise the Staff that we determined that this was a triggering event under paragraph 8 of SFAS 144 that required us to test our long-lived assets for recoverability. As a result of this testing, the Company determined that no impairment reserve was required as the fair market value of these two plants was substantially above the carrying value.

Note 2

– Summary of Significant Accounting Policies, page F-9
Read in the reply
Note 2 – Summary of Significant Accounting Policies, page F-9
SEC asked (16)
Please disclose in future filings the line item(s) in which you include depreciation and amortization. If you do not allocate a portion of your depreciation and amortization to cost of goods sold, please also revise your presentation to comply with SAB Topic 11:B, which would include revising the cost of goods sold title and removing any references in the filing to gross profit.
Rest of the question

Please show us in your supplemental response what the revisions will look like.

JHX answered
Beginning with the Company’s second quarter ended September 30, 2009 consolidated financial statements, which were furnished via Form 6-K on November 25, 2009 (the “6-K”), the Company added the following disclosure related to depreciation and amortization. This disclosure will continue to be included in future filings.

Depreciation and Amortization

The Company records depreciation and amortization under both cost of goods sold and selling, general and administrative expenses, depending on the asset’s business use.
Rest of the answer

All depreciation and amortization related to plant buildings, machinery and equipment is recorded in cost of goods sold.

Read in the reply
Restricted Cash and Cash Equivalents, page F-9 and Restricted Cash and Cash · Equivalents – Asbestos, F-19
SEC asked (17)
Please expand your disclosure in future filings to discuss the restrictions on restricted cash and cash equivalents, including the length of time the cash is restricted, and tell us what consideration you gave to presenting restricted cash as a non-current asset on the face of your balance sheets. Please show us in your supplemental response what the revisions will look like.
JHX answered
In future filings on Form 20-F, the disclosure for Restricted Cash and Cash Equivalents on page F-9 will be enhanced as follows:

Restricted Cash and Cash Equivalents

Restricted cash and cash equivalents relate to amounts subject to letters of credit with insurance companies which restrict the cash from use for general corporate purposes.

will be furnished via Form 6-K), the Company will classify its restricted cash between current and non-current amounts in its consolidated balance sheets based on the current and non-current classification of its estimated claims liability, since the
Rest of the answer

letters of credit are in place for the purpose of paying current claims liabilities. Had the Company classified its restricted cash on this basis in the 20-F, the restricted cash balances would have been as follows:

March 31

2009

2008

Restricted cash and cash equivalents — current

0.3

1.5

Restricted cash and cash equivalents — non-current

5.0

3.5 statements, which were furnished via the 6-K, the disclosure on page F-15 for Restricted

Cash and Cash Equivalents related to Asbestos was enhanced as follows. This disclosure will continue to be included in future filings.

Cash and cash equivalents of the AICF are reflected as restricted assets, as the use of these assets is restricted to the settlement of asbestos claims and payment of the operating costs of the AICF. The

Company classifies these amounts as a current asset on the face of the consolidated balance sheet since they are highly liquid.

Read in the reply
Earnings Per Share, page F-13
SEC asked (18)
Please disclose in future filings how you are treating the restricted shares you have issued in computing both your basic and diluted earnings per share. Your disclosure should enable a reader to understand how you treat both vested and unvested restricted shares for basic EPS and for diluted EPS.
Rest of the question

If applicable, please separately disclose how you treat unvested shares that vest based solely on continued employment, as well as those that vest subject to conditions. See paragraphs 10 and 13 of SFAS 128. Please show us in your supplemental response what the revisions will look like.

JHX answered
statements, which were furnished via the 6-K, the following additional disclosure was included. This disclosure will continue to be included in future filings.

Unless antidilutive, restricted stock units (“RSUs”) which vest solely based on continued employment are considered to be outstanding as of their issuance date for purposes of computing diluted EPS and are included in the calculation of diluted EPS using the Treasury Method.

Once these RSUs vest, they are included in the basic EPS calculation on a weighted-average basis.

RSUs which vest based on performance or market conditions are
Rest of the answer

considered contingent shares. At each reporting date prior to the end of the contingency period, the Company determines the number of contingently issuable shares to include in diluted EPS, as the number of shares that would be issuable under the terms of the RSU arrangement, if the end of the reporting period were the end of the contingency period. Once these RSUs vest, they are included in the basic EPS calculation on a weighted-average basis.

Read in the reply
Note 10 – Product Warranties, page F-22
SEC asked (19)
Please enhance your disclosure in future filings to present a summary of the warranty liability activity for the most recent three years rather than two years. Refer to paragraph 14 of FIN 45.
JHX answered
In future filings on Form 20-F, we will enhance our disclosure to present a summary of the warranty liability activity for the most recent three years rather than two years.
Read in the reply
Note 13 – Commitment and Contingencies, page F-29
SEC asked (20)
You disclose on page 14 that you entered into an indemnity agreement in connection with the sale of your former United States gypsum wallboard manufacturing facilities in April 2002. Please consider disclosing in future filings the nature of this indemnity agreement, as well as any other material indemnity agreements you have entered into, within your commitments and contingencies footnote.
JHX answered
As of March 31, 2009, we were not aware of any asbestos-related claims arising from the U.S.

gypsum wallboard manufacturing facilities since the sale in April 2002. As a result, we did not include the gypsum indemnity agreement in Note 13 on page F-29 of the 20-F. This indemnity is, however, disclosed in risk factors section under Item 3 (page 14) and in the

Material Contracts section under Item 10 (page 115-116) of the 20-F.
Rest of the answer

In future filings on

Form 20-F, we will consider disclosing the nature of the gypsum indemnity agreement if we anticipate or become aware of any asbestos-related claims arising from this indemnity, as well as any other material indemnity agreements we have entered into, within our commitments and contingencies footnote.

Read in the reply
Note 14 – Income Taxes, page F-32
SEC asked (21)
Given your disclosure on page 9 that you may not have sufficient Australian taxable income in future years to utilize the tax deductions resulting from the funding payments under the Amended FFA to the AICF, please enhance your disclosure in future filings to discuss the positive and negative evidence you considered in reaching your conclusion that a valuation allowance was not necessary for a significant portion of
Rest of the question

your deferred tax assets as of March 31, 2009. Refer to paragraphs 20 to 25 of SFAS 109. Show us in your supplemental response what the revisions will look like. * * * * Please respond to these comments within 10 business days, or tell us when you will provide us with a response. Please provide us with a response letter that keys your responses to our comments and provides any requested information. Detailed letters greatly facilitate our review. Please file your supplemental response on EDGAR as a correspondence file. Please understand that we may have additional comments after reviewing your responses to our comments.

JHX answered
In future filings on Form 20-F, the disclosure on page F-33 will be enhanced as follows:

In determining the need for and the amount of a valuation allowance in respect of the Company’s asbestos related deferred tax asset, management reviewed the relevant empirical evidence, including the current and past core earnings of the Australian business and forecast earnings of the Australian business considering current trends.

Although realization of the deferred tax asset will occur over the life of the Amended FFA, which extends beyond our forecast period for the Australian business, Australia
Rest of the answer

provides an unlimited carryforward period for tax losses. Based upon managements’ review, the Company believes that it is more likely than not that the Company will realize its asbestos related deferred tax asset and that no valuation allowance is necessary as of March 31, 2009. Later, based on review of the empirical evidence by management at that time, if management determines that realization of its asbestos related deferred tax asset is not more likely than not, the Company may need to provide a valuation allowance to reduce the carrying value of the asbestos related deferred tax asset to its realizable value.

* * * *

You may call the undersigned with any questions or comments you may have regarding this letter at 31 20 301 6794. In addition, please send all written correspondence directly to the undersigned, with copies to James J. Moloney of Gibson, Dunn & Crutcher LLP, 3161 Michelson Drive, 12th Floor,

Irvine, California 92612, facsimile (949) 475-4756.

Read in the reply
Restricted Cash and Cash Equivalents, page F-9 and Restricted Cash and Cash · Equivalents – Asbestos, F-19
SEC asked
We have reviewed your response to prior comment 17 of our letter dated November 4, 2009. Your response indicates that cash and cash equivalents of the AICF are reflected as restricted assets, as the use of these assets is restricted to the settlement of asbestos claims and payment of the operating costs of the AICF and that you classify these amounts as a current asset on the face of the consolidated balance sheet
Rest of the question

since they are highly liquid. On the face of your balance sheet as of March 31, 2009, you present current restricted cash and cash equivalents related to asbestos in the amount of $45.4 million and current restricted short-term investments related to asbestos in the amount of $52.9 million, while your current asbestos liability is $78.2 million. Given your restricted current assets related to asbestos are greater than your current asbestos liability, please tell us what consideration you gave to presenting certain amounts of restricted assets related to asbestos as non-current assets. In this regard, we note your intention to record cash and cash equivalents between current and non-current amounts in your consolidated balance sheets based on the current and non-current classification of your estimated claims liability. * * * * Please respond to this comment within 10 business days, or tell us when you will provide us with a response. Please provide us with a response letter that keys your response to our comment and provides any requested information. Detailed letters greatly facilitate our review. Please file your supplemental response on EDGAR as a correspondence file. Please understand that we may have additional comments after reviewing your response to our comment.

JHX answered
We note the Staff’s comment asking what the Company considered in presenting certain amounts of restricted assets related to asbestos as non-current assets and the Company’s intentions with respect to recording cash and cash equivalents between current and non-current amounts in our balance sheets based on the current and non-current classification of our estimated claims liability.

We respectfully submit that it is the Company’s intention to record cash and cash equivalents between current and non-current amounts in our balance sheets based on the current and non-current classification of
Rest of the answer

our estimated insurance claims liability with respect to certain letters of credit (with insurance companies) under which it is contractually obligated.

However, the Company’s restricted assets related to asbestos are not encumbered by such contractual obligations and can be and are used by the AICF without restriction to settle AICF liabilities and operating expenses and are not for the sole purpose of settling the AICF’s current asbestos liability. Accordingly, we believe the previously proposed presentation and approach to recording assets between current and non-current assets is appropriate.

***

You may call the undersigned with any questions or comments you may have regarding this letter at +31 20 301 6794. In addition, please send all written correspondence directly to the undersigned at facsimile +31 20 404 2544, with copies to James J. Moloney of Gibson, Dunn & Crutcher LLP, 3161

Michelson Drive, 12th Floor, Irvine, California 92612, facsimile (949) 475-4756.

Read in the reply

Also in this review: closing letter, 2010-01-05

Form 20-F

2008-01-31 to 2008-04-08 · 7 questions · 2 letters from the SEC, 2 from the company
Review closed 2008-04-08
Results discussion (MD&A)Legal and contingenciesRisk factorsReserves and insuranceSegmentsControls
FORM 20-F FOR THE YEAR ENDED MARCH 31, 2007 · Risk Factors, page 6
SEC asked (1)
In future filings, please provide the information investors need to assess the magnitude of the risk. For example, to the extent material to understanding the magnitude of the risk, provide the following quantitative information: • Quantify the payments to the special purpose fund that provides compensation for Australian asbestos-related personal injury claims against former companies of the James Hardie Group.
Rest of the question

• Quantify your indemnification obligations to the buyer of your former Gypsum manufacturing facilities for asbestos-related claims. • Quantify your indemnification obligations for costs, penalties, fees and expenses incurred by current or former directors, officers or employees of the James Hardie Group. • Quantify your reserves for warranty-related claims and legal proceedings.

JHX answered
In future filings, to the extent the Company can quantify the risks referenced in the

Staff’s comment and such risks are material, it will include quantitative information in its risk factor disclosures concerning such risks to the extent such matters are referenced in its risk factor disclosures. The Company notes, however, that certain risks, such as the exact amount of any specific future payments to the special purpose fund, beyond the following fiscal year, cannot be quantified, as such amounts are dependent on a variety of contingent factors, including the Company’s free cash flow
Rest of the answer

(defined as cash from operations in accordance with GAAP in force at the date of the Original Final Funding Agreement), actuarial estimations, actual claims paid, operating expenses of the special purpose fund, the exchange rate between the Australian dollar and the U.S. dollar and the annual cash flow cap. See Item 4, “Information on the Company — Legal Proceedings” in the 20-F for an explanation of these contingent factors. The Company will, however, in future filings include in its asbestos risk factor disclosure quantitative information about the anticipated payment to the special purpose fund for the following fiscal year, past payments to the special purpose fund and the total asbestos liability as of the reported period end.

Similarly, due to the contingent nature of the amounts, the Company also cannot quantify any future indemnification obligations for costs, penalties, fees and expenses incurred by current or former directors, officers or employees of the James Hardie Group.

Read in the reply
Item 5 – Operating and Financial Review and Prospects, page 47 · Year Ended March 31, 2007 Compared to Year Ended March 31, 2006, page 52
SEC asked (2)
We note that you discuss the changes in net sales in Australian dollars in a more comprehensive manner that your discussion of changes in your US dollar sales. For example, you indicate that net sales for your Asia Pacific Fiber Cement segment increased 4% from $241.8 million in fiscal 2006 to $251.7 million in fiscal year without addressing the reasons for increase in US dollar sales of 4%.
Rest of the question

You do however disclose that in your Asia Pacific Fiber Cement segment, net sales in Australian dollars increased 2% due to a 6% increase in sales volume from 368.3 million square feet to 390.8 million square feet, partly offset by a 3% decrease in the average Australian dollar net sales price. Please revise to adequately discuss and quantify the reasons for the changes in your US dollar sales.

JHX answered
The difference between the increase in U.S. dollars of 4% compared to the increase in

Australian dollars of 2% for the Company’s Asia Pacific Fiber Cement Net Sales is, as disclosed, entirely due to the change in the Australian dollar to U.S. dollar exchange rate.

This currency related difference between the U.S. dollar and Australian dollar amounts is described in the Company’s summary of Total Net Sales which precedes the referenced disclosure.
Rest of the answer

See the first paragraph on page 52 which states: “Net sales from Asia Pacific

Fiber Cement increased 4% from $241.8 million in fiscal year 2006 to $251.7 million in fiscal year 2007 due to increased sales volumes and favorable currency exchange rate differences, partially offset by a decreased average net sales price.”

Read in the reply
Controls and Procedures, page 118
SEC asked (3)
We note your disclosure that controls and procedures can provide only “reasonable assurance” regarding management’s control objectives. Please confirm to us, and revise future filings to clarify, if true, that your officers concluded that your disclosure controls and procedures are effective at the reasonable assurance level. 12.
Rest of the question

Commitments and Contingencies, page F-20 Commitment to provide funding on a long-term basis in respect of asbestos-related liabilities of former subsidiaries, page F-20

JHX answered
Based on the Company’s evaluation as of March 31, 2007 of the effectiveness of the design and operations of its disclosure controls and procedures, the Company confirms that its certifying officers concluded that its disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2007, to ensure that the information required to be disclosed in the reports the Company files or submits under the Exchange Act were recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information was
Rest of the answer

accumulated and communicated to the

Company’s management, including the Company’s Chief Executive Officer and Chief Financial

Officer, to allow for timely decisions regarding required disclosures.

Assuming that the Company’s certifying officers reach similar conclusions from an evaluation of its disclosure controls and procedures as of the end of the period covered in any future filing, it will state in such filing that its certifying officers concluded that its disclosure controls and procedures were effective at the reasonable assurance level as of the end of such period to ensure that the information required to be disclosed in the reports the Company files or submits under the Exchange Act were recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information was accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, to allow for timely decisions regarding required disclosures.

Commitment to Provide Funding on a Long-term Basis in Respect of Asbestos-Related Liabilities of Former Subsidiaries — Page F-20

Read in the reply
Controls and Procedures, page 118
SEC asked (4)
On page F-21, you indicate that as of March 31, 2007 the undiscounted value of the central estimate of the asbestos-related liabilities of Amaca and Amaba as determined by KPMG Actuaries was approximately $2.3 billion.
Rest of the question

You further indicate that this central estimate was calculated in accordance with Australian Actuarial Standards, which differ from accounting principles generally accepted in the United States of America and that this undiscounted central estimate is net of expected insurance recoveries of $393 million. You also indicate that the undiscounted range of potential costs was $1.3 billion to $4.1 billion. We assume that, based on these disclosures and your tabular presentation presented on page F-22 that for US GAAP purposes, specifically FIN14, there was no amount within your range of loss that was a better estimate than any other amount such that you accrued the lower end of the range of loss. Please revise your disclosures to better clarify your accounting. In addition, please further clarify that for US GAAP purposes, specifically FIN39, you have not net the $393 million insurance recoveries against your asbestos-related liabilities and that pursuant to paragraph 140 of SOP 96-1 you have only recorded probable insurance recoveries. Please revise your disclosures throughout the filing to provide these clarifying disclosures.

JHX answered
At March 31, 2006, the Company determined that it was appropriate to record a provision for what had become a probable and estimable liability. The amount that was recorded was based on the terms of the proposed FFA, which included an actuarial estimate prepared by KPMG Actuaries (“KPMGA”) as of March 31, 2006 of the projected future cash outflows, undiscounted and uninflated, and the anticipated tax deduction arising from Australian legislation which came into force on April 6, 2006.

Following the finalization of the asbestos funding arrangements in February 2007, the 20-F includes
Rest of the answer

additional disclosure intended to help the reader assess the Company’s asbestos liability. In arriving at the provision value, the Company again relied on an estimate provided by KPMGA. Based on KPMGA’s assumptions, KPMGA arrived at a range of possible total cash flows, although as part of their work they proposed a central estimate which is intended to reflect an expected outcome. The Company views the central estimate as the basis for recording the asbestos liability in the Company’s financial statements, which, under U.S. GAAP, it considers the best estimate under SFAS 5. The Company will add clarifying disclosures in future filings.

Furthermore, as stated on page F-14, the Company based the value of the liability on undiscounted and uninflated cash flows as it believes that it is inappropriate to discount or inflate future cash flows when the timing and amounts of such cash flows is not fixed or readily determinable.

In an effort to provide additional information and to indicate the impact of inflation on the future cash flows, the Company refers to the undiscounted (but inflated) central estimate of A$2.8 billion on pages F-21 and F-23. It is the Company’s view that when read in conjunction with the accounting policy on page F-14, the reader is better able to determine how and why the Company arrived at the level of liability recorded. In future filings the

Company will use the words “but inflated” where appropriate.

The table on page F-22 is intended to show how the Company’s liability under the funding arrangements is presented on the Company’s balance sheet. The Company confirms that in accordance with FIN 39, it has not netted the $393 million insurance recoveries against its asbestos-related liabilities. The Company notes that this table includes amounts for the asbestos liability, the receivables for insurance and all other components of the liability which are recorded on a gross basis as separate items which agree to the captions on the balance sheet.

The Company confirms that only probable insurance recoveries have been recorded in accordance with paragraph 140 of SOP 96-1. The Company has included such clarifying disclosure in its recent financial statements and it is the Company’s intention to continue including such disclosure in its future filings. See the Company’s financial statements for the quarter ended June 30, 2007, furnished to the SEC on August 17, 2007 on Form 6-K.

Read in the reply
Controls and Procedures, page 118
SEC asked (5)
We note your tabular presentation of the adjustments to the net Amended FFA liability presented on page F-21. For readers of your US GAAP financial statements, please also provide a rollforward of your gross asbestos liability for each balance sheet date presented. Separately disclose changes in your estimated future asbestos-related liabilities from your from your funding payments.
Rest of the question

In this regard, we note that you recognized $405.5 million in asbestos adjustments during the year ended March 31, 2007. Your disclosures on page 54 indicate that $335.0 million of this adjustment relates to the tax effect related to the implementation of the Final Funding Agreement. Please clarify supplementally and revise your disclosures to clarify why taxes impact your FFA liability and the related provision you have recognized during the period.

JHX answered
No rollforward of the asbestos-related assets and liabilities was included in the 20-F because the balance sheet contained in the 20-F was the first balance sheet to include the liability on a gross basis. However, the Company has included this presentation in its recent financial statements, and it is the Company’s intention to continue including this presentation, in its future filings.
Rest of the answer

See the Company’s financial statements for the quarter ended June 30, 2007, furnished to the SEC on August 17, 2007 on Form 6-K.

At March 31, 2006, the Company recorded an asbestos provision based on the estimated economic reality of the proposed FFA. The amount of the asbestos provision of $715.6 million was based on the terms of the proposed FFA, which included an actuarial estimate prepared by KPMGA as of March 31, 2006 of the projected future cash outflows, undiscounted and uninflated, and the anticipated tax deduction arising from Australian legislation which came into force on April 6, 2006. The amount represented the net economic impact that the

Company was prepared to assume as a result of its voluntary funding of the asbestos liability which was under negotiation with various parties.

Upon signing of the FFA in 2007, in accordance with Financial Accounting Standards Board

Interpretation No. 46R, “Consolidation of Variable Interest Entities”, the Company consolidated the AICF with the Company resulting in a gross-up of the asbestos liability and certain other items including the related Australian income tax benefit. Among other items, the Company recorded a deferred tax asset for the anticipated tax benefit related to recorded charges and a corresponding increase in the asbestos liability. As stated on page

F-14, the Company’s Performing Subsidiary, James Hardie 117 Pty Ltd, will be able to claim a taxable deduction for contributions to the asbestos fund. In the Company’s 2007 statement of operations, the Company classified the expense related to the increase of the asbestos liability as asbestos adjustments and the Company classified the benefit related to the recording of the related deferred tax asset as income tax benefit (expense).

Read in the reply
Australian Securities and Investments Commission (“ASIC”) Proceedings and · Investigation, page F-25
SEC asked (6)
You indicate that there remains considerable uncertainty surrounding the likely outcome of the ASIC proceedings in the long term and there is a possibility that the related costs could be material. However, at this stage, it is not possible to determine the amount of such liability. Therefore, both the probable and estimable requirements under SFAS 5 for recording a liability have not been met.
Rest of the question

While the probable and estimable requirements for recording a liability may not have been met, you indicate that there is a possibility that the related costs could be material. Please tell us and disclose whether there is at least a reasonable possibility that a loss has been incurred as well as the corresponding possible loss or range of loss resulting from the ASIC proceedings. Refer to paragraph 10 of SFAS 5. * * * * Please respond to these comments with in 10 business days, or tell us when you will provide us with a response. Please provide us with a response letter that keys your responses to our comments and provides any requested information. Detailed letters greatly facilitate our review. Please file your response on EDGAR as a correspondence file. Please understand that we may have additional comments after reviewing your responses to our comments.

JHX answered
Based on the information available to the Company at March 31, 2007, the Company believed it was reasonably possible that amounts will be incurred in relation to the ASIC proceedings.

However, the actual amount or range of amounts was not estimable. The Company will provide clarifying disclosure to that effect in future filings assuming that at the time of such filing, the

Company still believes that it is reasonably possible that amounts will be incurred in relation to the ASIC proceedings but the actual amount or range of amounts is not estimable.

***

You may call the undersigned with
Rest of the answer

any questions or comments you may have regarding this letter at 31 20 301 6794. In addition, please send all written correspondence directly to the undersigned, with copies to Gary Epstein at Greenberg Traurig, P.A., 1221 Brickell Avenue, Miami,

Florida 33131, telecopy (305) 579-0717.

Read in the reply
Item 5 – Operating and Financial Review and Prospects, page 47 · Year Ended March 31, 2007 Compared to Year Ended March 31, 2006, page 52
SEC asked
We have read your response to comment two from our letter dated January 31, 2008. On page 5, you indicate that net sales from Asia Pacific Fiber Cement increased 4% from $241.8 in fiscal year 2006 to $251.7 million in fiscal year 2007 due to the increased sales volume and favorable currency exchange rate differences, partially offset by a decreased average net sales prices.
Rest of the question

In future filings, please quantify the impact of each business reason mentioned above within your discussion of Asia Pacific Fiber Cement Net Sales on a US dollar basis. * * * * Please respond to this comment within 10 business days, or tell us when you will provide us with a response. Please provide us with a response letter that keys your responses to our comments and provides any requested information. Detailed letters greatly facilitate our review. Please file your response on EDGAR as a correspondence file. Please understand that we may have additional comments after reviewing your responses to our comments.

JHX answered
In future filings, the Company will quantify the impact of any material changes in foreign exchange rates, sales volumes and the average net sales prices within its discussion of Asia

Pacific Fiber Cement Net Sales on a U.S. dollar basis.

***

You may call the undersigned with any questions or comments you may have regarding this letter at 31 20 301 6794. In addition, please send all written correspondence directly to the undersigned, with copies to Gary Epstein at Greenberg Traurig, P.A., 1221 Brickell Avenue, Miami,

Florida 33131, telecopy (305) 579-0717.
Read in the reply

Also in this review: closing letter, 2008-04-08

Letters without questions

Other letters

UPLOAD and CORRESP
3 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 31 letters filed since 2008-01-31. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/JHX/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.